The FTSE 100 ended the week up 1.75%, with the Small Caps index up 1.4%.
Ananda (AQSE:ANA) Developments Secures Funding for Endometriosis Clinical Trial
Ananda Developments Plc (AQSE: ANA), a developer of cannabinoid medicines, has secured the necessary funding to initiate a trial to test the effectiveness of its cannabidiol oil, MRX1, in treating
Ananda Developments (AQSE:ANA) First Cannabinoid Medicines Launched
Ananda’s ambition is to be a leading provider of high-quality cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.
Company Profile (AQSE:ANA) Ananda Developments
Ananda Developments (AQSE: ANA) is an AQUIS-listed healthcare company involved in the development of cannabinoid-based medicines with two concurrently running, third-party funded, Phase II randomised control trials (RCTs).
Traders Cafe with Zak Mir: Bulletin Board Heroes, Wednesday 17th May 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Asimilar Group, Ananda
Trader’s Café With Zak Mir: The Week In Small Caps, Sunday 26th March 2023
Now that it has been established how necessary the Lockdown was, one can appreciate being allowed out in the open air even more than before.
Zak Mir talks to Melissa Sturgess, CEO Ananda Developments
In the wake of the MRX Global acquisition, and what this means for the medical cannabis group
Ananda Developments Plc (ANA.L) Grant of Home Office Licence
The Directors of Ananda announce the following progress regarding Ananda’s vision to become a significant participant in the emerging medicinal cannabis sector:
Ananda Developments (ANA:AQSE) Into The Bargain Basement Zone?
It is clear that since the arrival of Covid-19 this year, investors have had to totally change they look at the financial markets, and perhaps more importantly, who the new
Ananda Developments plc (TIDM: ANA) Admission to trading on the NEX Exchange
Ananda Developments plc (TIDM: ANA) is pleased to announce that trading in the 329,166,666 ordinary shares of 0.2 pence each in the Company (“Ordinary Shares”) shall commence at 8.00am,